Alaunos Therapeutics Inc. (TCRT) Fundamentals

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.
SHARE INFORMATION
Market Cap$ 201,395,190
Shares Outstanding216,182,042
Float184,835,575
Percent Float85.5%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 398,000
Latest Fiscal EPS$ -0.38
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions303
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months7,367,106
Institutional Holdings Percent53.3%
Institutional Sold Previous 3 Months33,818,244
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months815,000
Insider Holdings Percent4.7
Insider Sold Previous 3 Months18,750
Insider Shares Owned10,164,756
TRADING INFO
52 Week High$ 4.01
52 Week Low$ 0.41
52 Week High Change$ -34.85
21 Day Moving Average$ 1.0585
21 Day Extended Moving Average$ 1.0752
50 Day Moving Average$ 1.3994
50 Day Extended Moving Average$ 1.3258
200 Day Moving Average$ 1.1846
200 Day Extended Moving Average$ 1.4253
10 Day Average Volume1,357,955
20 Day Average Volume1,188,628
30 Day Average Volume1,364,259
50 Day Average Volume3,501,434
Alpha0.016069
Beta0.1829
Standard Deviation0.324891
R20.000888
7 Day Price Change$ 0.031
7 Day Percent Change3.44%
21 Day Price Change$ -0.1784
21 Day Percent Change-16.07%
30 Day Price Change$ -0.1984
30 Day Percent Change-17.56%
Month to Date Price Change$ -0.2184
Month to Date Percent Change-18.99%
Quarter to Date Price Change$ -0.7884
Quarter to Date Percent Change-45.84%
180 Day Price Change$ 0.4148
180 Day Percent Change80.26%
200 Day Price Change$ 0.2416
200 Day Percent Change35.01%
Year to Date Price Change$ -0.1584
Year to Date Percent Change-14.53%

Alaunos Therapeutics Inc. (TCRT) Key Ratios

PROFITABILITY
EBIT Margin-1,283.4%
EBITDA Margin-1,188.3%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 2,911,000
Revenue Per Share$ 0.0135
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.40
Total Debt To Equity0.80
Int Coverage-12.40
Current Ratio1.70
Leverage Ratio1.80
Quick Ratio1.20
Long Term Debt To Capital0.07
VALUATION MEASURES
PE Ratio-4.70
Enterprise Value$ 191,639,902
Price to Sales69.1842
Price to Free Cash-5.40
PE High Last 5 Years7.50
Price To Book6.40
Price To Cash Flow42.40
PE Low Last 5 Years-3.00
Price to Tangible Book6.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.30
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-44.58
Return on Equity-80.07
Return on Capital-47.90

Alaunos Therapeutics Inc. (TCRT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRSM US LLP
CEOKevin S. Boyle
Emplyoees41
Last AuditUQ
CIK0001107421
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address8030 El Rio Street
Navy Yard Plaza
Houston, TX 77054
Websitehttps://www.alaunos.com
Facsimile+1 617 241-2855
Telephone+1 346 355-4099
Emailctaylor@ziopharm.com


Your Recent History
NASDAQ
TCRT
Alaunos Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.